Status:
UNKNOWN
Warning Model of Myocardial Remodeling After Acute Myocardial Infarction Using Multimodal Feature Structure Technology
Lead Sponsor:
Xuanwu Hospital, Beijing
Collaborating Sponsors:
Beijing Institute of Technology
Conditions:
Myocardial Infarction
Eligibility:
All Genders
18-80 years
Brief Summary
Acute myocardial infarction (AMI) is one of the most important diseases threatening human life. The existing MI prognosis prediction scales mostly predict the incidence of death, recurrent MI and hear...
Eligibility Criteria
Inclusion
- Patients with acute myocardial infarction, aged 18-80 years; 2.The time from onset to treatment is less than 72h 3.Myocardial enzyme Tni/Tnt(+).
Exclusion
- Patients with malignant tumors; 2.Patients who could not receive conventional treatment 3.Patients who did not receive coronary angiography, lacking anatomical and imaging data; 4.Patients who have undergone cardiac surgery (except coronary artery bypass surgery)
Key Trial Info
Start Date :
October 10 2022
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
June 1 2024
Estimated Enrollment :
4000 Patients enrolled
Trial Details
Trial ID
NCT06062316
Start Date
October 10 2022
End Date
June 1 2024
Last Update
April 30 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Xuanwu Hospital, Capital Medical University
Beijing, Xicheng, China, 100000